©Author(s) (or their employer(s)) 2026.
World J Crit Care Med. Mar 9, 2026; 15(1): 113889
Published online Mar 9, 2026. doi: 10.5492/wjccm.v15.i1.113889
Published online Mar 9, 2026. doi: 10.5492/wjccm.v15.i1.113889
Table 1 Significance of key parameters used in rotational thromboelastometry and thromboelastography
| Parameter on ROTEM | Parameter on TEG | Definition | Significance |
| CT | Reaction time | Time to 2 mm clot firmness amplitude | Reflects coagulation factor activity and thrombin generation |
| Clot formation time | Kinetic time | Time from 2 mm to 20 mm clot firmness amplitude | Reflects fibrin polymerization, stabilization of the clot with platelets and factor XIII |
| α angle | α angle | Angle between the baseline and a tangent to the clotting curve through the 2 mm point | Reflects fibrin polymerization, stabilization of the clot with platelets and factor XIII |
| MCF | MA | The MA reached during the test | Reflects clot strength depending on platelets, fibrinogen, factor XIII |
| Lysis index at 30 minutes, 45 minutes, 60 minutes after CT | Lysis index at 30 minutes, 60 minutes after MA (Ly30, 60) | The residual clot firmness at 30 minutes, 45 minutes, 60 minutes after CT (ROTEM) in percentage of MCF. The reduction in clot firmness at 30 minutes, 60 minutes after MA (TEG) in percentage of MA | Reflects clot lysis depending on fibrinolytic activators or inhibitors, factor XIII, and platelet-mediated clot retraction |
Table 2 Classic and cartridge-based assays for rotational thromboelastometry and thromboelastography
| Assay (platform) | Activator/reagent | Main pathway assessed/information |
| ROTEM Delta EXTEM | Tissue factor | Extrinsic |
| ROTEM Delta INTEM | Ellagic acid | Intrinsic |
| ROTEM Delta FIBTEM | Tissue factor + cytochalasin D (platelet inhibitor) | Fibrinogen, factor XIII |
| ROTEM Delta HEPTEM | INTEM reagents + heparinase | Intrinsic, heparin effect |
| ROTEM Sigma Complete cartridge | Includes EXTEM, INTEM, FIBTEM, APTEM | - |
| ROTEM Sigma Complete + heparin cartridge | Includes EXTEM, INTEM, FIBTEM, HEPTEM | - |
| TEG 5000 CK | Kaolin | Intrinsic |
| TEG 5000 CKH | Kaolin + heparinase | Intrinsic, heparin effect |
| TEG 5000 CRT | Tissue factor (RapidTEG) | Extrinsic |
| TEG 5000 CFF | Functional fibrinogen (tissue factor + GPIIb/IIIa inhibitor) | Fibrinogen, factor XIII |
| TEG 6S® Global Hemostasis Cartridge | Includes CK, CK with heparinase, citrated RapidTEG, and citrated functional fibrinogen | - |
- Citation: Scarlatescu E. Viscoelastic testing: Transforming hemostasis management in patients in the medical intensive care unit. World J Crit Care Med 2026; 15(1): 113889
- URL: https://www.wjgnet.com/2220-3141/full/v15/i1/113889.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v15.i1.113889
